Enlivex Therapeutics (Enlivex Therapeutics) Accumulated other comprehensive income (loss) : $1.10 Mil (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Enlivex Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Enlivex Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2023 was $1.10 Mil.

Enlivex Therapeutics's quarterly Accumulated other comprehensive income (loss) stayed the same from Mar. 2023 ($1.10 Mil) to Jun. 2023 ($1.10 Mil) and stayed the same from Jun. 2023 ($1.10 Mil) to Sep. 2023 ($1.10 Mil).

Enlivex Therapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2020 ($0.98 Mil) to Dec. 2021 ($1.10 Mil) but then stayed the same from Dec. 2021 ($1.10 Mil) to Dec. 2022 ($1.10 Mil).

Enlivex Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Enlivex Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlivex Therapeutics Accumulated other comprehensive income (loss) Chart

Enlivex Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-1.30

0.98

1.10

Enlivex Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															1.10	1.10	1.10	1.10	1.10

Enlivex Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Enlivex Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Enlivex Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Enlivex Therapeutics (Enlivex Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enlivex Therapeutics Ltd (NAS:ENLV) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ENLV:Israel 1BT:Germany

Address

14 Einstein Street, Nes Ziona, ISR, 7403618

Website

https://www.enlivex.com

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.